SynthesisBMJ medicine2026

Values, preferences, and treatment burden for initiation of GLP-1 receptor agonists, SGLT-2 inhibitors, tirzepatide, and finerenone in adults with type 2 diabetes: systematic review.

Daniela C González-Cruz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.